tnf inhibitor

Green L, Armstrong A, Han G, Jacobson A. Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure.[...]

Aung T, Celestin M. Infliximab-Induced Vasculitis in a Rheumatoid Arthritis Patient: A Comprehensive Case Report. Cureus. 2025 Apr 17;17(4):e82467. doi: 10.7759/cureus.82467. PMID: 40385904; PMCID: PMC12085235.